You are here: Home :: Keyword index :: tim bis Zos :: tubulopathy - twin gestations tumor marker

Items for "tumor marker"

Multicenter evaluation of the analytical and clinical performance of the Elecsys ^® S100 immunoassay in patients with malignant melanoma

The aim of this multicenter study was to evaluate the technical and clinical performance of the Elecsys ^® S100 electrochemiluminescence immunoassay and to assess its utility as a tumor marker in patients with malignant melanoma...

Keywords: Malignant melanoma, S100, tumor marker

05/2005 | Clinical Chemical Laboratory Medicine, Walter de Gruyter

Technical evaluation of the Beckman Coulter OV-Monitor (CA 125 antigen) immunoassay

Background: The CA 125 antigen is a large (200–1000 kDa) glycoprotein, present within normal and benign ovarian tissue...

Keywords: Abbott AxSYM, Bayer ADVIA Centaur, CA 125, immunoassay, ovarian cancer, tumor marker, UniCel? DxI 800

04/2006 | Clinical Chemical Laboratory Medicine, Walter de Gruyter

Sandwich ELISAs for soluble immunoglobulin superfamily receptor translocation-associated 2 (IRTA2)/FcRH5 (CD307) proteins in human sera

Background: The immunoglobulin superfamily receptor translocation-associated 2 (IRTA2) gene encodes both membrane and secreted forms of the B-cell differentiation antigen (also identified as FcRH5)...

Keywords: B-cell differentiation antigen, CD307, enzyme immunoassay, hairy cell leukemia, immunotoxin, tumor marker

05/2006 | Clinical Chemical Laboratory Medicine, Walter de Gruyter

Interchangeability of measurements of CA 19-9 in serum with four frequently used assays: an update

Background: CA 19-9 is a marker principally related to pancreatic and gall bladder cancer...

Keywords: analytical performance, CA 19-9 determination, comparability, tumor marker

01/2007 | Clinical Chemical Laboratory Medicine, Walter de Gruyter

CEA und CA15-3 beim fortgeschrittenen Mammakarzinom / CEA and CA 15-3 during disease progression in metastatic breast cancer

Zusammenfassung Fragestellung: Das Ziel der deskriptiven Analyse war es, eine Korrelation zwischen erhhten Werten von carcinoembryonalem Antigen (CEA) und Cancer Antigen (CA) 15-3 und dem Fortschreiten der Erkrankung bei Patientinnen mit metastasiertem Mammakarzinom zu zeigen. Patienten und Methoden: Fr die Studie wurden die Krankengeschichten und Befunde von Patientinnen retrospektiv analysiert, die im Zeitraum Januar 1992 bis Dezember 2004 im Klinikum Mnchen Grohadern behandelt wurden...

Keywords: Cancer Antigen (CA) 15-3, carcinoembryonales Antigen (CEA), metastasiertes Mammakarzinom, Tumormarker, carcino-embyronic antigen (CEA), metastatic breast cancer, tumor marker

04/2007 | LaboratoriumsMedizin, Walter de Gruyter

Publisher and Institutes